Autism Definition, Symptoms and Treatments Review H1 2017

Autism  
Overview
Clinical trial report, “Autism Global Clinical Trials Review, H1, 2017" provides an overview of Autism clinical trials scenario. This report provides top line data relating to the clinical trials on Autism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1418129-autism-global-clinical-trials-review-h1-2017
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months


Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Autism to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Autism to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20 
 …Continued
 For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1418129-autism-global-clinical-trials-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Baby Food and Care Market, Trends, Absolute Opportunity and Value Chain 2017

Baby Food and Care  
Overview
"Top Trends in Baby Food and Care 2017" focuses on outlining the key consumer and innovation trends currently impacting the baby food and baby care categories. Specifically, this report explores how new trends influencing modern consumers' lives, such as smart technology and fear of germs, influence the baby food, baby beverages, baby toiletries, and diapers categories.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1418086-top-trends-in-baby-food-and-care-2017-exploring-the-baby
Baby Food and Care Industry Major Outlook
The Categories in the baby food sector continue to evolve, driven by the parental desire to provide their children with the best products available, as well as to increase the efficacy of the processes involved in caring for their babies. Specifically, products that address concerns regarding germs and the spread of disease are popular, as are those with healthful credentials. Increasingly sophisticated innovation is also evident in this sector, as influenced by a wealth of trends impacting the adult food, drink, and personal care sectors. People are also incorporating increasingly smart solutions into their lives to make parental responsibilities less burdensome.

Scope
- Over a third of parents agree that working out what food and drinks are healthy for their children is confusing.
- Over two thirds of parents pay high or very high attention to the ingredients used in products they buy for their children.
- More parents are aware of what the term "clean label" is when asked, compared with non-parents.


Reasons to buy
- Understand the relevant consumer trends and attitudes that drive and support innovation success so you can tap into what is really impacting the industry.
- Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
- Access valuable strategic take-outs to help direct future decision-making and inform new product development.


Table of Contents
Table of Contents
Introduction
Innovation Trends in Baby Food and Baby Care
Smart Parenting
Hyper-Protection
Health Haven
Adultification
The Future
Appendix

 …Continued
 For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1418086-top-trends-in-baby-food-and-care-2017-exploring-the-baby
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Recent Study Explores West Nile Virus Infections Pipeline Review, H1 2017

West Nile Virus Infections  
Overview
West Nile infection is caused by a virus transmitted by mosquitoes. The West Nile virus is a type of virus known as a Flavivirus. Symptoms include a fever, headache, body aches, skin rash, and swollen lymph glands. Risk factors for developing a more severe form of West Nile virus include conditions that weaken the immune system, such as HIV, organ transplants, and recent chemotherapy, age and pregnancy.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1248525-west-nile-virus-infections-pipeline-review-h1-2017
West Nile Virus Infections Industry Major Outlook
The Pharmaceutical and Healthcare latest pipeline guide West Nile Virus Infections – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for West Nile Virus Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The West Nile Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for West Nile Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I, Preclinical and Discovery stages are 3, 8 and 2 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 3 and 3 molecules, respectively.
West Nile Virus Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.



Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of West Nile Virus Infections (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for West Nile Virus Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
Reasons to buy
- The pipeline guide provides a snapshot of the global therapeutic landscape of West Nile Virus Infections (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for West Nile Virus Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
West Nile Virus Infections - Overview
West Nile Virus Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
West Nile Virus Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
…Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1248525-west-nile-virus-infections-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Latest Study Offers Detailed Insights on Chlamydia Infections H1 2017

Chlamydia Infections  
Overview
Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and pain and swelling around the testicles. Predisposing factors include age, multiple sex partners and history of prior sexually transmitted infection. Treatment includes antibiotics and pain medicine.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1248521-chlamydia-infections-pipeline-review-h1-2017
Chlamydia Infections Industry Major Outlook
The Pharmaceutical and Healthcare latest pipeline guide Chlamydia Infections – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chlamydia Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Chlamydia Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chlamydia Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Discovery stages are 1, 1, 9 and 2 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 4 molecules, respectively.
Chlamydia Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.



Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Chlamydia Infections (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Chlamydia Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.


Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Chlamydia Infections (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chlamydia Infections - Overview
Chlamydia Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Chlamydia Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
 …Continued
 For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1248521-chlamydia-infections-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Graft Versus Host Disease (GVHD) Professional Survey about Therapeutics and Pipeline Review H1 2017

Graft Versus Host Disease (GVHD)  

Overview

Graft-versus-host disease (GVHD) is a complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted donor cells attack the transplant recipient's body. Symptoms include abdominal pain or cramps, nausea, vomiting, and diarrhea, dry or irritated eyes, jaundice, shortness of breath, vaginal dryness and weight loss. Treatment includes immunosuppressants.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1248519-graft-versus-host-disease-gvhd-pipeline-review-h1-2017

Graft Versus Host Disease (GVHD) Industry Major Outlook

The Pharmaceutical and Healthcare latest pipeline guide Graft Versus Host Disease (GVHD) – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Graft Versus Host Disease (GVHD) (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Graft Versus Host Disease (GVHD) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Graft Versus Host Disease (GVHD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 1, 7, 23, 11, 35, 7 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 3, 13 and 2 molecules, respectively.

Graft Versus Host Disease (GVHD) (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Graft Versus Host Disease (GVHD) (Immunology).
- The pipeline guide reviews pipeline therapeutics for Graft Versus Host Disease (GVHD) (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Graft Versus Host Disease (GVHD) (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies. 

Table of Contents
Table of Contents 2
Introduction 5
Graft Versus Host Disease (GVHD) - Overview 6
Graft Versus Host Disease (GVHD) - Therapeutics Development 7
Graft Versus Host Disease (GVHD) - Therapeutics Assessment 22
Graft Versus Host Disease (GVHD) - Companies Involved in Therapeutics Development 34
Graft Versus Host Disease (GVHD) - Drug Profiles 65
Graft Versus Host Disease (GVHD) - Dormant Projects 369
Graft Versus Host Disease (GVHD) - Discontinued Products 373
Graft Versus Host Disease (GVHD) - Product Development Milestones 374
Appendix 385

 …Continued

 For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1248519-graft-versus-host-disease-gvhd-pipeline-review-h1-2017

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Psoriasis Market Growth and Restrain Factors Analysis By 2022

Psoriasis  
Overview
Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up skin, itchiness, and burning sensation, swollen and stiff joints. Predisposing factors include heredity, side effects of certain medicines, stress, infections and environmental conditions. The condition may be controlled by topical or systemic medications and phototherapy.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1248517-psoriasis-pipeline-review-h1-2017
Psoriasis Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Psoriasis – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Psoriasis (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Psoriasis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Psoriasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 14, 1, 21, 44, 42, 1, 103, 32 and 9 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 8 and 6 molecules, respectively.
Psoriasis (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Psoriasis (Immunology).
- The pipeline guide reviews pipeline therapeutics for Psoriasis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Psoriasis (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
Table of Contents
Table of Contents 2
Introduction 8
Psoriasis - Overview 9
Psoriasis - Therapeutics Development 10
Psoriasis - Therapeutics Assessment 39
Psoriasis - Companies Involved in Therapeutics Development 55
Psoriasis - Drug Profiles 130
Psoriasis - Discontinued Products 607
Psoriasis - Product Development Milestones 610
Appendix 619
List of Tables
Number of Products under Development for Psoriasis, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
 …Continued
 For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1248517-psoriasis-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Household Cleaning and Laundry Market Trends, Size and Growth Analysis 2017 To 2022

Household Cleaning and Laundry  
Overview
"Top Trends in Household Cleaning and Laundry 2017" focuses on outlining the key consumer and innovation trends currently impacting household cleaning and laundry care. These include NPD that aligns with gender-specific concerns, the consumer interest in product effects on both health and the environment, more complex scent offerings, and convenience.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1418083-top-trends-in-household-cleaning-and-laundry-2017-the-latest-trends
Household Cleaning and Laundry Industry Major Outlook
In the household cleaning and laundry sector, the consumer desire for more holistic, natural cleaning products is evident, making products that preserve and protect both environmental and human health popular. It is also noticable that time-scare consumers value products that require minimal time and labor commitments and that deliver maximum efficacy, inspiring product innovation throughout the sector. Additionally, scent is increasingly becoming a point of differentiation, with fragrance being used to convey cleanliness and luxury. As brands move away from a "one-size-fits-all" approach, products that capitalize on the rising male participation in household chores are emerging.

Scope
- Over a third of consumers globally give high or very high attention to the ingredients used in the househod care and laundry products they buy.
- Over a third of consumers globally find the time-saving/convenience of using a single product the most appealing benefit of multifunctional household care products.
- Over two thirds of males globally believe that men have an equal responsibility to women when it comes to shopping/cooking/cleaning.

Reasons to buy
- Understand the relevant consumer trends and attitudes that drive and support innovation success so you can tap into what is really impacting the industry.
- Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
- Access valuable strategic take-outs to help direct future decision-making and inform new product development.

Table of Contents
Table of Contents
Introduction
Innovation Trends in Household Cleaning and Laundry Care
Scent-Sory Appeal
Convenient Cleaning
Green Cleaning
Targeting Male Consumers
Conclusions
The Future
Appendix
 …Continued
 For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1418083-top-trends-in-household-cleaning-and-laundry-2017-the-latest-trends
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)